Pharmaceutical Sector Declared 'Incredibly Cheap' for Investment by SEB Analyst

Fredrik Warg, an analyst at SEB, has emphasized the pharmaceutical sector as a prime opportunity for investors, describing it as 'incredibly cheap' and the best investment option available. Speaking during a segment on Börsmorgon on September 29, 2025, he underscored his bullish outlook on the sector amidst broader positive trends in the Swedish stock market. Despite a decline in shares of AB Volvo, the market opened positively, with analysts praising H&M's robust performance and recommending Atlas Copco as a staple in investment portfolios.

Warg’s insights reflect a growing optimism not only for the pharmaceutical industry but also for other Swedish entities. He noted that Afry's stock is expected to rise significantly in the upcoming week. Furthermore, Warg highlighted the recent launch of SEB's stablecoin, which he believes has substantial differences compared to Bitcoin, indicating a shift in investment strategies.

Amid these discussions, Warg also raised concerns about political instability in the United States, viewing it as a pressing threat for market dynamics. He regarded Verisure's recent valuation as underwhelming, suggesting that announcing a high price might be detrimental. Overall, Warg's commentary paints a picture of cautious optimism, suggesting a favorable environment for investors in the pharmaceutical sector and select Swedish companies.